Home › Bronchiolitis Obliterans Syndrome › Georgia
Bronchiolitis Obliterans Syndrome clinical trials in Georgia
11 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Georgia.
Cities in Georgia
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Children's Healthcare of Atlanta - Egleston Hospital- Site Number : 8400003, Atlanta
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Clayton Eye Clinical Research, Morrow
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Emory University-Winship Cancer Institute, Atlanta
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Childrens Healthcare of Atlanta, Atlanta
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
RecruitingPhase 2
Ages 34 to 80 · All sexes · Updated Sep 14, 2026 · NCT05584124Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Emory University, Atlanta
- Georgia Cancer Center, Augusta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Emory University, Atlanta
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Blood and Marrow Transplant Group of Georgia, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
- Northside Hospital, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT06046248A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Emory University Winship Cancer Institute, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Freedom-1 Study for Chronic Knee Pain
- Southern Pain and research, Jasper
- Vista Clinical Research/Summit Spine & Joint Centers, Newnan
Recruiting
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT03877653From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.